US2012053321A1PendingUtilityA1
Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
Est. expiryApr 19, 2022(expired)· nominal 20-yr term from priority
Inventors:Wenfeng XuStacy SchlutsmeyerCameron S. BrandtWayne R. KindsvogelKatherine E. HendersonTheodore E. WhitmoreKevin M. Klucher
C07K 14/7155
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel methods are disclosed for forming a heterodimeric receptor complex with IL-28R and CRF2-4. The methods may be used for detecting and treating viral infections in in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A cultured cell comprising an expression vector comprising the following operably linked elements:
a) a first transcription promoter; a first DNA segment encoding a first receptor subunit comprising amino acid residues 21-520 of SEQ ID NO:19; and a first transcription terminator; and b) a second transcription promoter; a second DNA segment encoding a second receptor subunit comprising the amino acid residues of SEQ ID NO:64; and a second transcription terminator; wherein the first receptor subunit and the second receptor subunit form a heterodimeric receptor capable of binding a polypeptide comprising amino acid residues 20-200 of SEQ ID NO:55.
18 . The cultured cell of claim 17 , wherein the cultured cell is prokaryotic.
19 . The cultured cell of claim 17 , wherein the cultured cell is eukaryotic.
20 . A cultured cell comprising:
a) a first expression vector comprising:
i) a first transcription promoter;
ii) a first DNA segment encoding a first receptor subunit comprising amino acid residues 21-520 of SEQ ID NO:19; and
iii) a first transcription terminator; and
b) a second expression vector comprising:
i) a second transcription promoter;
ii) a second DNA segment encoding a second receptor subunit comprising the amino acid sequence of SEQ ID NO:64; and
iii) a second transcription terminator; and
wherein the first receptor subunit and the second receptor subunit form a heterodimeric receptor capable of binding a polypeptide comprising amino acid residues 20-200 of SEQ ID NO:55.
21 . The cultured cell of claim 20 , wherein the cultured cell is prokaryotic.
22 . The cultured cell of claim 20 , wherein the cultured cell is eukaryotic.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.